Finance

Lists
000538:SHE
Yunnan Baiyao Group Co Ltd
CN¥ ५३.०८
+०.३४%
(+०.१८) 1D
अक्टोबर १६, १५:०४:३० GMT+८  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000538...
Open
CN¥ ५२.८९
High
CN¥ ५३.६६
Low
CN¥ ५२.५२
Mkt. cap
९४.७१ अरब
Avg. vol.
७५.२४ लाख
Volume
१.२९ करोड
Dividend
४.९४%
Quarterly dividend
CN¥ ०.६६
Ex-dividend date
२०२६ अप्रिल ३०
P/E ratio
१८.१४
52-wk high
CN¥ ५८.२०
52-wk low
CN¥ ४६.२९
EPS
CN¥ २.९३
Shares outstanding
१.७८ अरब
No. of employees
९ हजार
Open
CN¥ ५२.८९
High
CN¥ ५३.६६
Low
CN¥ ५२.५२
Mkt. cap
९४.७१ अरब
Avg. vol.
७५.२४ लाख
Volume
१.२९ करोड
Dividend
४.९४%
Quarterly dividend
CN¥ ०.६६
Ex-dividend date
२०२६ अप्रिल ३०
P/E ratio
१८.१४
52-wk high
CN¥ ५८.२०
52-wk low
CN¥ ४६.२९
EPS
CN¥ २.९३
Shares outstanding
१.७८ अरब
No. of employees
९ हजार
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
८ मिनेट पहिले
The Call Airbnb Bulls Got Right
Stock Traders Daily
Stock Traders Daily
·
४ घण्टा पहिले
Avoiding Lag: Real-Time Signals in (ABCL) Movement
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd
CEO-
Employees९.२९ हजार
Founded१९०२
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
९.४० अरब
१०.५३ अरब
११.६० अरब
१०.२८ अरब
Cost of goods sold
६.७० अरब
७.८५ अरब
८.०५ अरब
७.२८ अरब
Cost of revenue
६.७० अरब
७.८५ अरब
८.०५ अरब
७.२८ अरब
Research and development expenses
७.९१ करोड
११.५५ करोड
७.६८ करोड
११.२८ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.३९ अरब
२.३७ अरब
१.२८ अरब
१.५० अरब
Operating expense
१.३३ अरब
२.६७ अरब
१.४४ अरब
१.६४ अरब
Total operating expenses
८.०३ अरब
१०.५२ अरब
९.४८ अरब
८.९२ अरब
Operating income
१.३७ अरब
१.२८ करोड
२.१२ अरब
१.३६ अरब
Other non operating income
-४.३३ करोड
१३.५९ करोड
-१.७४ करोड
३.७९ करोड
EBT including unusual items
१.३८ अरब
४२.८२ करोड
२.३६ अरब
१.९२ अरब
EBT excluding unusual items
१.४७ अरब
२३.३८ करोड
२.३५ अरब
१.७४ अरब
Income tax expense
२३.८७ करोड
२.७४ करोड
३३.०३ करोड
२५.५० करोड
Effective tax rate
१७.२५%
६.४०%
१३.९९%
१३.२७%
Other operating expenses
-१.८९ करोड
१३.०० करोड
६५.३७ लाख
११.६७ करोड
Net income
१.१४ अरब
३७.६४ करोड
२.०४ अरब
१.६६ अरब
Net profit margin
१२.१८%
३.५७%
१७.५६%
१६.१८%
Earnings per share
०.६१
०.१८
१.१०
०.८७
Interest and investment income
१३.७० करोड
१०.७३ करोड
२५.३४ करोड
३६.७७ करोड
Interest expense
-४३.९५ लाख
-८८.३४ लाख
-५०.८५ लाख
-५१.५१ लाख
Net interest expenses
१३.२६ करोड
९.८४ करोड
२४.८३ करोड
३६.२५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.४२ अरब
७.०९ करोड
२.१८ अरब
१.४३ अरब
Gain or loss from assets sale
२२.६३ लाख
-८१.६८ लाख
-
-३.०५ हजार
AI content may include mistakes. Learn more
Google एपहरू